Approval · Notice of Compliance 26072 · 2021
POLYFLEX: Notice of Compliance 26072
Issued June 15, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26072
- Date
- June 15, 2021
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Manufacturing Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| POLYFLEX | 00849405 | Marketed |
Medicinal ingredients
- AMPICILLIN TRIHYDRATE 25 G per VIAL